What happened
Shares of the specialty biopharmaceutical company RedHill Biopharma(NASDAQ:RDHL) are down by an eye-popping 33% as of 10:53 a.m. EDT Tuesday morning. The drugmaker’s stock is tanking today in response to the performance of opaganib, a sphingosine…
Is the Fortescue share price a buy in March?
March 3, 2026
